Table 4:
Unadjusted Results | Final Multivariable Model N=170 | |||||
---|---|---|---|---|---|---|
Variable | Odds Ratio* | 95% Confidence Interval | P-value | Odds Ratio* | 95% Confidence Interval | P-value |
Epilepsy type | 0.10 | 0.08 | ||||
Generalized versus focal | 2.57 | 0.84–7.89 | 0.10 | 3.30 | 1.02–10.66 | 0.05 |
Unknown versus focal | 4.75 | 0.60–37.85 | 0.14 | 3.62 | 0.44–29.94 | 0.23 |
Depression score** | 1.13 | 1.03–1.25 | 0.008 | 1.13 | 1.01–1.26 | 0.03 |
Current antidepressant therapy*** | 2.61 | 1.26–5.43 | 0.01 | 2.37 | 1.04–5.41 | 0.04 |
Odds of opting-in to research screening
Odds per one-point increase in score on the NDDI-E
SSRI, SNRI, mirtazapine, bupropion, or buspirone